Technology | Quality Assurance (QA) | April 27, 2016

IBA Releases Dolphin Online Ready Patient QA and Monitoring System

System enables more efficient pre-treatment patient QA, with future online treatment monitoring for safer delivery of each treatment fraction enabled after linac interoperability confirmation

IBA, Dolphin ONline Read Patient QA and Monitoring, quality assurance

April 27, 2016 — IBA (Ion Beam Applications S.A.) announced the release of Dolphin Online Ready Patient QA and Monitoring. Dolphin enhances workflows in pre-treatment QA (quality assurance), while being mindful of future online treatment monitoring.

To achieve added efficiency, Dolphin offers a “plug-and-play” design that enables significantly faster pre-treatment QA. Dolphin only requires two minutes to set up and wirelessly transmits the measured detector response to the Dolphin workstation. Additionally, the new automatic verification software QuickCheck saves valuable time by providing instant analysis of the Dolphin measurements and giving an “OK” message for the tests successfully passed.

This design ensures that Dolphin will enable future online treatment monitoring by measuring the actual delivery during patient treatment and by automatic QuickCheck verification immediately after each fraction, seamlessly integrating into the therapist’s workflow.

“The Dolphin will offer the possibility for online verification of complex dose delivery techniques such as IMRT [intensity modulated radiation therapy] or VMAT [volumetric modulated arc therapy] with the patient already in treatment position. Used for multiple treatment fractions the system even offers inherently a new possibility for cumulative delivered dose tracking,” said Dr. Hansjoerg Wertz, Dept. of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany in the name of the whole “Dolphin team” at UMM. “The novel online QA system contributes to reduce extra pre-treatment QA time to a minimum while at the same time increasing patient safety and preventing severe accidents due to the immediate detection of dose delivery errors. Based on our intensive initial experiences, we are planning to implement Dolphin into our clinical routine workflow for our patient verification during treatment as soon as possible. This gives us the ultimate confidence in treating our patients safely.”

Dolphin offers not only a simple consistency check but is coupled with the advanced analysis of each measured dose, and in turn, offers a complete patient QA solution. The clinical relevance of the dose discrepancies is comprehensively determined with DVH and in 3-D patient anatomy using sophisticated TPS-Class verification software. Following this verification process, the clinical team can determine whether re-planning or plan adaptation is needed or machine-specific parameters can be verified.

Dolphin is also designed for future applications, such as Machine QA and Adaptive-QA using cone beam computed tomography (CBCT) and dose of the day. The versatility of Dolphin makes it the universal detector for integrating future real time measurements into IBA’s myQA global QA platform for several key dosimetry applications, from Patient QA to Machine QA and more.

For more information: www.iba-worldwide.com

Related Content

RayStation Replacing Existing Treatment Planning System at Leeds Cancer Centre
News | Treatment Planning | September 24, 2018
RaySearch recently strengthened its position in the U.K. market with a major order for the treatment planning system...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...